Latest news

Here you can hear the latest goings-on and news from the Prescribing Observatory for Mental Health.

To support sampling and preparation for our upcoming audit, the eligibility criteria and practice standards for our next QI programme Topic 7g: Monitoring of patients prescribed lithium, have now been released POMH member Trusts.

The audit tool and support materials for this Topic will be provided shortly after our POMH webinar event: An update on the POMH QI programme 'Monitoring of patients prescribed lithium' on 8 February 2023

We'd like to thank all members that have completed their POMH membership renewal for 2023. 

For members that intend to renew but have not yet applied, you can find our online form here: Renew your membership

We are pleased to confirm that the slide-sets for Topic 1h & 3e: Prescribing antipsychotics including high dose, combined and PRN have now been released and are available for POMH members to download via from the online Members' Area.

We would like to provide a short update on progress of our current QI programmes:

Topic 1h & 3e: Prescribing antipsychotics including high dose, combined and PRN

Digital copies of the reports are now available on our POMH members' area. We hope to release the bespoke slide-sets to participating Trusts in the New Year.

Topic 20b: Quality of valproate prescribing in adult mental health services

Thank you to all that submitted data for this QI programme. Data collection is now closed. Trust raw datasets and any data cleaning queries will be sent out to participating Trusts in the New Year.

Topic 21a: Use of melatonin

Data analysis for the melatonin Topic continues. Reports are due to be released in January or early February next year, 2023.

Topic 7g: Monitoring of patients prescribed lithium

Our upcoming webinar on this Topic will be held on February 8th 2023, 1.00-2.30pm. Our guest speaker will be Professor Hamish McAllister-Williams. We invite members to register their attendance here: Registration page.

We are pleased to confirm that our re-audit report for Topic 1h and 3e: 'Prescribing antipsychotics including high dose, combined and PRN' has now been released.

The report is available to members of POMH only and can be downloaded from the online Members' Area.

We are pleased to confirm the dates next year for our continuing webinar series in support of our QI programme for 2023. 

POMH members will receive a separate invitation to book their free place nearer the time. All relevant colleagues with interest in this QI work are welcome to join.

Visit our events page for the dates and times.

Please note that the dates for our QI programmes in 2023 have been revised. We hope these changes will allow members more time for planning and preparation at the start of the year.

Due to ongoing staff shortages, we have also revised the upcoming reporting periods for the current QI programme topics.

Our calendar planner for 2023 has been updated to reflect these changes.

Calendar planners for our audits and other materials can also be found on the POMH resources page.

The Prescribing Observatory for Mental Health initiated a quality improvement (QI) programme on valproate use in UK mental health services.

A paper on this topic has now been published in the Journal of Psychopharmacology: 'Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit'. A link to the paper and further publications by POMH can be found on our resources page.

Our new calendar planner for 2023 is now available. A link to this can be found on our resources page.

We are pleased to confirm that the slide-sets for Topic 19b 'Prescribing for depression in adult mental health services' have now been released and are available for POMH members to download via from the online Members' Area.

The Prescribing Observatory for Mental Health initiated a quality improvement (QI) programme on clozapine use in UK mental health services.

A paper on this topic has now been published in the Journal of Psychopharmacology: 'Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit'.

A link to the paper and further publications by POMH can be found on our resources page.

We are pleased to confirm that our re-audit report for Topic 19b 'Prescribing for depression in adult mental health services' has now been released.

The report is available to members of POMH only and can be downloaded from the online Members' Area.

In 2020, POMH conducted a service evaluation outside of our planned QI programme in response to a (rescinded) Supply Disruption Alert (SDA) on the discontinuation of the Priadel brand of lithium.

The results from this service evaluation has now been published in the BJPsych Bulletin: 'Plus ça change? Switching lithium preparations'.

A link to the paper and further publications by POMH can be found on our resources page.

Read more to receive further information regarding a career in psychiatry